CHARLES GREEN: Open Payments
NPI 1962574285 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 43 payments from 10 companies in 2025. Trend: 2023 $591 · 2024 $684 · 2025 $798
Food & beverage: $716Education: $83
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $323 |
| E.R. Squibb & Sons, L.L.C. | 9 | $157 |
| UCB, Inc. | 3 | $60 |
| Galderma Laboratories, L.P. | 3 | $57 |
| Organon LLC | 6 | $50 |
| GENZYME CORPORATION | 1 | $37 |
| Janssen Biotech, Inc. | 1 | $32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $31 |
| ABBVIE INC. | 1 | $30 |
| LEO Pharma Inc. | 1 | $21 |
Products named: COSENTYX, Sotyktu, Bimzelx, NEMLUVIO, VTAMA, DUPIXENT, TREMFYA, ILUMYA.
Industry payments across MI — which companies pay providers there.
